The Global Biopharma Buffer Market Growth Accelerated By Increased Focus On Production Of Novel Biologics
 |
| Biopharma Buffer Market |
Biopharma buffers are indispensable tools used for the
production and development of biologic drugs, vaccines and other bioprocess
applications. They help maintain a stable physiological pH level and
appropriate ion concentration during various biochemical reactions like cell
culture, purification, and formulation processes. The growing demand for biopharmaceuticals
like monoclonal antibodies, recombinant proteins and gene therapies is driving
significant focus on developing novel biologics. This necessitates high
performance biopharma buffers that can efficiently support upstream and
downstream bioprocessing.
The global Biopharma Buffer Market is estimated to be valued
at US$ 3.68 Bn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted
in a new report published by Coherent Market Insights.
Market key trends:
The increased focus on production of novel biologics from major
pharmaceutical players has been a key trend shaping the biopharma buffer market
in recent years. Biologics producers are actively investing in R&D to
develop advanced pipeline candidates like gene therapies, stem cell therapies
and cell and gene editing applications to treat chronic diseases. This requires
high quality buffers to efficiently support the complex large-scale production
processes of novel biologics. Leading buffer manufacturers are accordingly
strengthening their capabilities to fulfill the stringent quality and
performance requirements for advanced bioprocessing. They are also expanding
buffer portfolios with novel product formulations that can facilitate enhanced
yields for emerging biologic classes. This focus on developing customized
solutions is expected to boost adoption of high-end biopharma buffers.
Segment Analysis
The global Biopharma Buffer market is segmented based on type, application,
end user and geography. By type, the market is segmented into Phosphate Buffer,
TRIS Buffer, Acetate Buffer and Other. TRIS buffer segment dominated the market
and held the maximum market share in 2023, TRIS buffers are the most common and
versatile buffer systems used in biopharmaceutical manufacturing processes due
to their high buffering capacity and ability to maintain neutral pH conditions.
By application, the market is divided into Recombinant DNA Cloning, Protein
Purification, Cell Culture, and Other Applications. Protein Purification
dominated the market owing to wide applications of buffer in downstream and
upstream processing of biomanufacturing.
Key Takeaways
The global
Biopharma Buffer market analysis is expected to witness high growth.
The global Biopharma Buffer Market is estimated to be valued at US$ 3.68 Bn in
2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to
2030.
Regional analysis shows that North America dominated the
market and is expected to continue its dominance during the forecast period.
Wide presence of key biopharmaceutical manufacturing facilities is driving the
market in the region.
Key players operating in the Biopharma Buffer market are Digital Medics Pty.
Ltd., Emperra GmbH E-Health Technologies, Merck KGaA, and Sorenson BioScience.
Digital Medics Pty. Ltd. is a leading manufacturer and supplier of bioprocess
solutions including buffers. The company offers several buffer systems
specifically tailored for different biopharmaceutical applications such as
protein purification and cell culture.
Get more insights on this topic: https://www.newswirestats.com/biopharma-buffer-market-industry-insights-trends-biopharma-buffer-market/
Explore more information on this topic, Please visit:
https://filmik.in/design-brilliance-unleashed-elevate-brands-with-the-expert-packaging-design-services/
Comments
Post a Comment